Full-Time

Manager – Tax

Corporate Finance

Posted on 8/25/2025

Evolent

Evolent

1,001-5,000 employees

Delivers value-based care through analytics

Compensation Overview

$110k - $125k/yr

+ Bonus

Company Does Not Provide H1B Sponsorship

Arlington, VA, USA

Hybrid

Local candidates only from DC, Maryland, or Virginia.

Category
Accounting (1)
Required Skills
Data Analysis
Requirements
  • BA/BS in Accounting/Finance
  • 4+ years of experience in public accounting and/or a high-growth public company
  • Deep expertise and technical aptitude related to tax accounting principles (ASC 740), business combinations, SOX, and federal and state income tax concepts
  • Strong interpersonal and communication skills (verbal and written)
  • Ability to multi-task, meet deadlines and thrive in a fast-paced, deadline-driven, and evolving work environment
  • Strong project management skills: ability to effectively lead implementation of key tax initiatives
  • Must be able to be hands on, detail-oriented, while being able to see the big picture
  • The person in this role must reside in the DC, Maryland or Virginia Area.
Responsibilities
  • Manage quarterly and annual ASC 740 tax provision for all US and international subsidiaries, including liaising with external auditors
  • Coordinate and support the federal, state, local and international income tax preparation process with external consultants
  • Prepare federal, state, and local extension and estimated tax calculations
  • Manage the indirect tax function, including sales and use, gross receipts, property, franchise, and other business taxes
  • Review/prepare reconciliation of general ledger tax accounts
  • Develop, research, and document tax issues and positions taken
  • Manage income tax audits
  • Maintain intercompany and transfer pricing arrangements among the domestic and foreign entities
  • Oversee the tax receivable agreement (TRA) models and related payments
  • Monitor relevant developments in tax policy and legislation and the impact on the Company
  • Participate in the SOX 404 compliance effort with respect to tax processes
  • Support systems development and improved analytics
  • Train and develop a tax associate in the US and interact with tax team in India
  • Other duties as assigned to support the success of the accounting department and company
Desired Qualifications
  • CPA certification is not required, however preferred.

Evolent Health helps healthcare organizations transition to value-based care by pairing technology, analytics, and clinical expertise to improve patient outcomes while lowering costs. It partners with health systems, physician groups, and health plans to deliver data-driven care coordination, population health management, and risk-adjustment services. The company’s offerings include software platforms, analytics, and clinical support that enable more efficient care delivery, shared savings programs, and performance-based incentives. Compared with competitors, Evolent emphasizes end-to-end collaboration with clients and a diversified client base, combining technology with hands-on clinical and operational expertise to drive measurable outcomes. Its goal is to help clients succeed in value-based models by delivering better patient care at lower total costs.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Arlington, Virginia

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Oncology launches with Highmark and Aetna drive $2.4-2.6B 2026 revenue guidance.
  • Performance Suite expansion generates over $200M annual revenue from new agreements.
  • Archie Mayani's 2026 appointment accelerates AI in prior authorizations and clinical support.

What critics are saying

  • 7x leverage and $398M Q4 2025 goodwill impairment trigger covenant breaches by mid-2027.
  • Q1 2026 6.9% revenue miss erodes confidence, limits capital access post-$145M notes.
  • Privia Health's 17.4% Q4 growth captures share as Evolent posts flat $468.7M revenue.

What makes Evolent unique

  • Evolent unifies oncology, cardiology, musculoskeletal solutions under single platform post-2023 rebrand.
  • Serves 41 million enrollees with clinician-led pathways and technology-enabled decision support.
  • Focuses exclusively on value-based specialty care after divesting primary care to Privia in 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Yahoo Finance
Mar 19th, 2026
Evolent appoints Archie Mayani as chief product officer to drive AI innovation in healthcare

Evolent Health has appointed Archie Mayani as chief product officer. Mayani brings over 20 years of experience in healthcare technology and AI innovation from roles at GHX, Change Healthcare, UnitedHealth Group and Amazon. Most recently, Mayani served as CPO at GHX, where she developed AI-powered capabilities for healthcare supply chains. At Change Healthcare, she led clinical decision support and revenue cycle platforms, focusing on reducing administrative burden in prior authorisation. During her time at Optum and UnitedHealth Group, she scaled value-based care programmes that improved Medicare STARS performance and reduced hospital utilisation. Mayani also served as global head of product and content operations for Amazon Prime Video. She has received multiple industry honours, including the Global CPO Award in 2025 and Inspiring Leader Award in 2023.

Yahoo Finance
Mar 7th, 2026
Evolent Health drops to $5.18 fair value on 7x leverage and $398M goodwill impairment

Evolent Health faces a shifting investment narrative after analysts reset expectations, with fair value estimates dropping from $8.50 to $5.18. The revision reflects concerns about reserves, leverage and margin visibility. Despite lowered price targets, Oppenheimer, BTIG, UBS, Citi, Truist and Canaccord maintain positive ratings, citing conservative reserving and new contracts as potential margin support. Analysts view new CFO Mario Ramos as bringing increased transparency. However, KeyBanc downgraded to Sector Weight, highlighting leverage at approximately 7x and limited EBITDA recovery visibility. Multiple firms reduced 2026-2028 earnings assumptions amid medical cost pressures and ACA exchange membership concerns. Evolent recorded a $398 million goodwill impairment for Q4 2025 and issued 2026 revenue guidance of $2.4 billion to $2.6 billion.

Yahoo Finance
Feb 25th, 2026
Evolent Health shares jump 20.7% on Q4 beat and strong 2026 revenue guidance

Evolent Health shares surged 20.7% after the healthcare solutions company reported fourth-quarter earnings that beat expectations and issued optimistic revenue guidance. The company posted non-GAAP earnings of $0.08 per share, significantly improved from a $0.02 per share loss a year earlier and ahead of analyst forecasts. Whilst quarterly revenue fell 27.5% year-on-year to $468.7 million, meeting expectations, investors focused on strong future guidance. Evolent projected full-year 2026 revenue between $2.4 billion and $2.6 billion, with the midpoint suggesting approximately 30% growth and nearly 5% above analyst estimates. The shares are trading at $3.15, down 19.2% year-to-date and 73.3% below their 52-week high of $11.79 from July 2025.

Pulse Nigeria
Sep 24th, 2025
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care

Privia Health acquires Evolent's ACO business to boost value-based care.

Healthcare Dive
Sep 24th, 2025
Privia acquires Evolent's value-based primary care unit for $100M

Privia Health is acquiring a value-based primary care business from Evolent Health as the physician enablement company continues to expand its care delivery network into new geographies.

INACTIVE